Oftan Dexa (Dexamethasone Sodium Phosphate)

Dexamethasone sodium phosphate, the active ingredient in Often Dexa, is a corticosteroid presented as a sterile injectable solution for intramuscular or intravenous use. It is employed to reduce inflammation and modify immune responses in a variety of acute and chronic medical conditions.

GNH USA supplies Oftan Dexa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and oncology centres worldwide.

Oftan Dexa is a corticosteroid that acts on inflammatory and immune pathways across several disease categories. - Allergic reactions: helps reduce severe hypersensitivity symptoms and airway swelling. - Autoimmune disorders: diminishes          ​                                                                                                                                                                                                                                                                ​ - Cerebral edema: lowers intracranial pressure associated with tumors or trauma. - Acute inflammation: provides rapid anti‑inflammatory effect in postoperative or traumatic settings.

Adverse reactions to dexamethasone sodium phosphate vary with dose, duration and route of administration.

Common Side Effects: - Hyperglycemia: elevated blood glucose levels, especially in diabetic patients. - Fluid retention: peripheral edema and weight gain. - Mood changes: irritability, anxiety or insomnia. - Gastrointestinal discomfort: nausea, abdominal pain or dyspepsia. - Local site reactions: pain, erythema or swelling at the injection site.

Serious or Rare Side Effects: - Severe infection: increased susceptibility to bacterial, fungal or viral infections. - Adrenal suppression: impaired endogenous cortisol production. - Osteonecrosis: bone tissue death, particularly in weight‑bearing joints. - Psychiatric effects: psychosis, severe depression or mania. - Hypersensitivity: anaphylaxis or severe allergic reactions.

When using dexamethasone sodium phosphate, clinicians should assess patient history and monitor for systemic effects. - Assess infection risk: evaluate for active or latent infections before initiating therapy. - Monitor glucose: check blood sugar levels in diabetic or pre‑diabetic patients. - Evaluate bone health: consider calcium and vitamin D supplementation for long‑term use. - Review psychiatric history: watch for mood or behavioral changes. - Store at ambient temperature: keep in original container, protect from light and moisture.

Dexamethasone sodium phosphate can modify the pharmacokinetics or pharmacodynamics of several co‑administered medicines.

Major Interactions (Avoid): - CYP3A4 inhibitors: may increase systemic exposure and risk of adverse effects. - Live vaccines: immunosuppression can reduce vaccine efficacy and increase infection risk. - Anticoagulants: enhanced anticoagulant effect leading to bleeding.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): additive risk of gastrointestinal ulceration. - Diuretics: may potentiate electrolyte disturbances, especially hypokalemia. - Antidiabetic agents: may require dose adjustment due to hyperglycaemic effect.